These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 28349257)

  • 21. Plant-based vaccines against respiratory diseases: current status and future prospects.
    Márquez-Escobar VA; Rosales-Mendoza S; Beltrán-López JI; González-Ortega O
    Expert Rev Vaccines; 2017 Feb; 16(2):137-149. PubMed ID: 27599605
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An assessment of enterotoxigenic Escherichia coli and Shigella vaccine candidates for infants and children.
    Walker RI
    Vaccine; 2015 Feb; 33(8):954-65. PubMed ID: 25482842
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Progress and hurdles in the development of vaccines against enterotoxigenic Escherichia coli in humans.
    Zhang W; Sack DA
    Expert Rev Vaccines; 2012 Jun; 11(6):677-94. PubMed ID: 22873126
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Review on pathogenicity mechanism of enterotoxigenic Escherichia coli and vaccines against it.
    Mirhoseini A; Amani J; Nazarian S
    Microb Pathog; 2018 Apr; 117():162-169. PubMed ID: 29474827
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preparation of porcine enterotoxigenic Escherichia coli (ETEC) ghosts and immunogenic analysis in a mouse model.
    Ran X; Chen X; Wang S; Chang C; Wen X; Zhai J; Ni H
    Microb Pathog; 2019 Jan; 126():224-230. PubMed ID: 30428380
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Production of Escherichia coli heat labile toxin (LT) B subunit in soybean seed and analysis of its immunogenicity as an oral vaccine.
    Moravec T; Schmidt MA; Herman EM; Woodford-Thomas T
    Vaccine; 2007 Feb; 25(9):1647-57. PubMed ID: 17188785
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel vaccine-adjuvant combination successful against bacterial diarrhea.
    Hum Vaccin Immunother; 2014; 10(12):3428. PubMed ID: 26052587
    [No Abstract]   [Full Text] [Related]  

  • 28. Development of a fast-dissolving tablet formulation of a live attenuated enterotoxigenic E. coli vaccine candidate.
    Lal M; Priddy S; Bourgeois L; Walker R; Pebley W; Brown J; Desai J; Darsley MJ; Kristensen D; Chen D
    Vaccine; 2013 Oct; 31(42):4759-64. PubMed ID: 23965220
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nanoparticulated heat-stable (STa) and heat-labile B subunit (LTB) recombinant toxin improves vaccine protection against enterotoxigenic Escherichia coli challenge in mouse.
    Deng G; Zeng J; Jian M; Liu W; Zhang Z; Liu X; Wang Y
    J Biosci Bioeng; 2013 Feb; 115(2):147-53. PubMed ID: 23040995
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The ectopic expression of the wheat Puroindoline genes increase germ size and seed oil content in transgenic corn.
    Zhang J; Martin JM; Beecher B; Lu C; Hannah LC; Wall ML; Altosaar I; Giroux MJ
    Plant Mol Biol; 2010 Nov; 74(4-5):353-65. PubMed ID: 20725765
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Designing vaccines to neutralize effective toxin delivery by enterotoxigenic Escherichia coli.
    Fleckenstein JM; Sheikh A
    Toxins (Basel); 2014 Jun; 6(6):1799-812. PubMed ID: 24918359
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunogenicity study of plant-made oral subunit vaccine against porcine reproductive and respiratory syndrome virus (PRRSV).
    Hu J; Ni Y; Dryman BA; Meng XJ; Zhang C
    Vaccine; 2012 Mar; 30(12):2068-74. PubMed ID: 22300722
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Coimmunization with Two Enterotoxigenic Escherichia coli (ETEC) Fimbrial Multiepitope Fusion Antigens Induces the Production of Neutralizing Antibodies against Five ETEC Fimbriae (F4, F5, F6, F18, and F41).
    Duan Q; Wu W; Pang S; Pan Z; Zhang W; Zhu G
    Appl Environ Microbiol; 2020 Nov; 86(24):. PubMed ID: 32169934
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preclinical Characterization of Immunogenicity and Efficacy against Diarrhea from MecVax, a Multivalent Enterotoxigenic E. coli Vaccine Candidate.
    Seo H; Garcia C; Ruan X; Duan Q; Sack DA; Zhang W
    Infect Immun; 2021 Jun; 89(7):e0010621. PubMed ID: 33875477
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Technical product attributes in development of an oral enteric vaccine for infants.
    White JA; Lal M
    Vaccine; 2019 Aug; 37(34):4800-4804. PubMed ID: 31358239
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Generation of transgenic corn-derived Actinobacillus pleuropneumoniae ApxIIA fused with the cholera toxin B subunit as a vaccine candidate.
    Shin MK; Jung MH; Lee WJ; Choi PS; Jang YS; Yoo HS
    J Vet Sci; 2011 Dec; 12(4):401-3. PubMed ID: 22122907
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Advances in new vaccines against human enterotoxigenic Escherichia coli--A review].
    Xia P; Meng X; Zhu G
    Wei Sheng Wu Xue Bao; 2016 Feb; 56(2):198-208. PubMed ID: 27373068
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Perspective: edible vaccines--a concept coming of age.
    Mor TS; Gómez-Lim MA; Palmer KE
    Trends Microbiol; 1998 Nov; 6(11):449-53. PubMed ID: 9846363
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Salmonella ghosts expressing enterotoxigenic Escherichia coli k88ab, k88ac, k99, and fasa fimbrial antigens induce robust immune responses in a mouse model.
    Hur J; Kim CS; Eo SK; Park SY; Lee JH
    Vet Q; 2015; 35(3):125-32. PubMed ID: 25853619
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enterotoxigenic Escherichia coli: advances in technical and laboratory aspects of research and development of vaccines.
    Wkly Epidemiol Rec; 2008 Mar; 83(10):92-5. PubMed ID: 18326111
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.